The total number of records retrieved from this search are 6. Click on ID to see further detail.

ID	Virus name	Virus strain	Virus genome type	Virus family	Virus genome modification	Virus alone	Virus in combination with drug/radiation	Immune gene insertion in viral genome	Source of cell line	Origin of cell line	Cell line	Concentration of cell line	In-vitro toxicity	Assay	In-vitro virus concentration	In-vitro result	Model organism	In-vivo virus concentration	In-vivo toxicity	In-vivo result	Mode of delivery	Pathway induced	Immunogenic effect	Clinical trial	PMID
IDOV_4085	Virus nameVaccinia virus	Virus strainVVstrain LIVP 6.1.1	Virus genome typeDNA	Virus familyPoxviridae	Virus genome modificationMutant for J2R gene	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineUniversity of veterinary medicine, germany	Origin of cell lineHuman mammary adenoma cell line	Cell lineZMTH3	Concentration of cell lineNA	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration0.1 MOI	In-vitro result90% cell survival after 24 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedNA	Immunogenic effectNA	Clinical trialNA	PMID26205404
IDOV_4089	Virus nameVaccinia virus	Virus strainVVstrain LIVP 6.1.1	Virus genome typeDNA	Virus familyPoxviridae	Virus genome modificationMutant for J2R gene	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineUniversity of veterinary medicine, germany	Origin of cell lineHuman mammary adenoma cell line	Cell lineZMTH3	Concentration of cell lineNA	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration0.1 MOI	In-vitro result30% cell survival after 48 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedNA	Immunogenic effectNA	Clinical trialNA	PMID26205404
IDOV_4093	Virus nameVaccinia virus	Virus strainVVstrain LIVP 6.1.1	Virus genome typeDNA	Virus familyPoxviridae	Virus genome modificationMutant for J2R gene	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineUniversity of veterinary medicine, germany	Origin of cell lineHuman mammary adenoma cell line	Cell lineZMTH3	Concentration of cell lineNA	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration0.1 MOI	In-vitro result10% cell survival after 72 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedNA	Immunogenic effectNA	Clinical trialNA	PMID26205404
IDOV_4097	Virus nameVaccinia virus	Virus strainVVstrain GLV-5b451	Virus genome typeDNA	Virus familyPoxviridae	Virus genome modificationDerived from LIVP6.1.1 by inserting glaf-2 gene into J2R locus	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineUniversity of veterinary medicine, germany	Origin of cell lineHuman mammary adenoma cell line	Cell lineZMTH3	Concentration of cell lineNA	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration0.1 MOI	In-vitro result95% cell survival after 24 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedNA	Immunogenic effectNA	Clinical trialNA	PMID26205404
IDOV_4101	Virus nameVaccinia virus	Virus strainVVstrain GLV-5b451	Virus genome typeDNA	Virus familyPoxviridae	Virus genome modificationDerived from LIVP6.1.1 by inserting glaf-2 gene into J2R locus	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineUniversity of veterinary medicine, germany	Origin of cell lineHuman mammary adenoma cell line	Cell lineZMTH3	Concentration of cell lineNA	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration0.1 MOI	In-vitro result30% cell survival after 48 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedNA	Immunogenic effectNA	Clinical trialNA	PMID26205404
IDOV_4105	Virus nameVaccinia virus	Virus strainVVstrain GLV-5b451	Virus genome typeDNA	Virus familyPoxviridae	Virus genome modificationDerived from LIVP6.1.1 by inserting glaf-2 gene into J2R locus	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineUniversity of veterinary medicine, germany	Origin of cell lineHuman mammary adenoma cell line	Cell lineZMTH3	Concentration of cell lineNA	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration0.1 MOI	In-vitro result25% cell survival after 72 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedNA	Immunogenic effectNA	Clinical trialNA	PMID26205404